{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T16:44:32Z","timestamp":1782578672230,"version":"3.54.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T00:00:00Z","timestamp":1501459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T00:00:00Z","timestamp":1501459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS089622"],"award-info":[{"award-number":["NS089622"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG047266"],"award-info":[{"award-number":["AG047266"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG055798"],"award-info":[{"award-number":["AG055798"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s40478-017-0458-0","type":"journal-article","created":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T15:07:13Z","timestamp":1501513633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau"],"prefix":"10.1186","volume":"5","author":[{"given":"Kevin H.","family":"Strang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall S.","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Riffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda D.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paramita","family":"Chakrabarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yona","family":"Levites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd E.","family":"Golde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit I.","family":"Giasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,31]]},"reference":[{"key":"458_CR1","doi-asserted-by":"publisher","first-page":"10626","DOI":"10.1021\/bi00158a027","volume":"31","author":"A Andreadis","year":"1992","unstructured":"Andreadis A, Brown WM, Kosik KS (1992) Structure and novel exons of the human tau gene. Biochemistry 31:10626\u201310633","journal-title":"Biochemistry"},{"key":"458_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1212\/WNL.42.3.631","volume":"42","author":"PV Arriagada","year":"1992","unstructured":"Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42:631\u2013639","journal-title":"Neurology"},{"key":"458_CR3","doi-asserted-by":"publisher","first-page":"9115","DOI":"10.1523\/JNEUROSCI.2361-07.2007","volume":"27","author":"AA Asuni","year":"2007","unstructured":"Asuni AA, Boutajangout A, Quartermain D, Sigurdsson EM (2007) Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements. J Neurosci 27:9115\u20139129. doi: 10.1523\/JNEUROSCI.2361-07.2007","journal-title":"J Neurosci"},{"key":"458_CR4","doi-asserted-by":"publisher","first-page":"e26860","DOI":"10.1371\/journal.pone.0026860","volume":"6","author":"M Bi","year":"2011","unstructured":"Bi M, Ittner A, Ke YD, Gotz J, Ittner LM (2011) Tau-targeted immunization impedes progression of neurofibrillary histopathology in aged P301L tau transgenic mice. PLoS One 6:e26860. doi: 10.1371\/journal.pone.0026860","journal-title":"PLoS One"},{"key":"458_CR5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.expneurol.2010.05.010","volume":"224","author":"M Boimel","year":"2010","unstructured":"Boimel M, Grigoriadis N, Lourbopoulos A, Haber E, Abramsky O, Rosenmann H (2010) Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice. Exp Neurol 224:472\u2013485. doi: 10.1016\/j.expneurol.2010.05.010","journal-title":"Exp Neurol"},{"key":"458_CR6","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1471-4159.2011.07337.x","volume":"118","author":"A Boutajangout","year":"2011","unstructured":"Boutajangout A, Ingadottir J, Davies P, Sigurdsson EM (2011) Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain. J Neurochem 118:658\u2013667. doi: 10.1111\/j.1471-4159.2011.07337.x","journal-title":"J Neurochem"},{"key":"458_CR7","doi-asserted-by":"publisher","first-page":"16559","DOI":"10.1523\/JNEUROSCI.4363-10.2010","volume":"30","author":"A Boutajangout","year":"2010","unstructured":"Boutajangout A, Quartermain D, Sigurdsson EM (2010) Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model. J Neurosci 30:16559\u201316566. doi: 10.1523\/JNEUROSCI.4363-10.2010","journal-title":"J Neurosci"},{"key":"458_CR8","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/BF00293315","volume":"87","author":"E Braak","year":"1994","unstructured":"Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87:554\u2013567","journal-title":"Acta Neuropathol"},{"key":"458_CR9","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960\u2013969. doi: 10.1097\/NEN.0b013e318232a379","journal-title":"J Neuropathol Exp Neurol"},{"key":"458_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0022-2836(77)90213-3","volume":"116","author":"DW Cleveland","year":"1977","unstructured":"Cleveland DW, Hwo SY, Kirschner MW (1977) Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J Mol Biol 116:207\u2013225","journal-title":"J Mol Biol"},{"key":"458_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0022-2836(77)90214-5","volume":"116","author":"DW Cleveland","year":"1977","unstructured":"Cleveland DW, Hwo SY, Kirschner MW (1977) Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J Mol Biol 116:227\u2013247","journal-title":"J Mol Biol"},{"key":"458_CR12","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1093\/brain\/awu213","volume":"137","author":"L Collin","year":"2014","unstructured":"Collin L, Bohrmann B, Gopfert U, Oroszlan-Szovik K, Ozmen L, Gruninger F (2014) Neuronal uptake of tau\/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer's disease. Brain 137:2834\u20132846. doi: 10.1093\/brain\/awu213","journal-title":"Brain"},{"key":"458_CR13","doi-asserted-by":"publisher","first-page":"e62402","DOI":"10.1371\/journal.pone.0062402","volume":"8","author":"C d'Abramo","year":"2013","unstructured":"d'Abramo C, Acker CM, Jimenez HT, Davies P (2013) Tau passive immunotherapy in mutant P301L mice: antibody affinity versus specificity. PLoS One 8:e62402. doi: 10.1371\/journal.pone.0062402","journal-title":"PLoS One"},{"key":"458_CR14","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1242\/jcs.114.6.1179","volume":"114","author":"HN Dawson","year":"2001","unstructured":"Dawson HN, Ferreira A, Eyster MV, Ghoshal N, Binder LI, Vitek MP (2001) Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J Cell Sci 114:1179\u20131187","journal-title":"J Cell Sci"},{"key":"458_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0891-0618(00)00100-9","volume":"20","author":"MS Forman","year":"2000","unstructured":"Forman MS, Lee VM, Trojanowski JQ (2000) New insights into genetic and molecular mechanisms of brain degeneration in tauopathies. J Chem Neuroanat 20:225\u2013244","journal-title":"J Chem Neuroanat"},{"key":"458_CR16","doi-asserted-by":"publisher","first-page":"10223","DOI":"10.1021\/bi980537d","volume":"37","author":"P Friedhoff","year":"1998","unstructured":"Friedhoff P, Schneider A, Mandelkow EM, Mandelkow E (1998) Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution. Biochemistry 37:10223\u201310230","journal-title":"Biochemistry"},{"key":"458_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/nan.12213","volume":"41","author":"B Ghetti","year":"2015","unstructured":"Ghetti B, Oblak AL, Boeve BF, Johnson KA, Dickerson BC, Goedert M (2015) Invited review: frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging. Neuropathol Appl Neurobiol 41:24\u201346. doi: 10.1111\/nan.12213","journal-title":"Neuropathol Appl Neurobiol"},{"key":"458_CR18","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1126\/science.1082324","volume":"300","author":"BI Giasson","year":"2003","unstructured":"Giasson BI, Forman MS, Golbe LI, Graves CL, Kotzbauer PT, Trojanoswki JQ, Lee VM-Y (2003) Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300:636\u2013640","journal-title":"Science"},{"key":"458_CR19","doi-asserted-by":"crossref","unstructured":"Goedert M, Jakes R, Vanmechelen E (1995) Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 189:167\u2013169","DOI":"10.1016\/0304-3940(95)11484-E"},{"key":"458_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","volume":"3","author":"M Goedert","year":"1989","unstructured":"Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3:519\u2013526","journal-title":"Neuron"},{"key":"458_CR21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/j.1460-2075.1989.tb03390.x","volume":"8","author":"M Goedert","year":"1989","unstructured":"Goedert M, Spillantini MG, Potier MC, Ulrich J, Crowther RA (1989) Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J 8:393\u2013399","journal-title":"EMBO J"},{"key":"458_CR22","doi-asserted-by":"publisher","first-page":"33081","DOI":"10.1074\/jbc.M113.494922","volume":"288","author":"J Gu","year":"2013","unstructured":"Gu J, Congdon EE, Sigurdsson EM (2013) Two novel tau antibodies targeting the 396\/404 region are primarily taken up by neurons and reduce tau protein pathology. J Biol Chem 288:33081\u201333095. doi: 10.1074\/jbc.M113.494922","journal-title":"J Biol Chem"},{"key":"458_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nm.3457","volume":"20","author":"JL Guo","year":"2014","unstructured":"Guo JL, Lee VM (2014) Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat Med 20:130\u2013138. doi: 10.1038\/nm.3457","journal-title":"Nat Med"},{"key":"458_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","volume":"15","author":"DP Hanger","year":"2009","unstructured":"Hanger DP, Anderton BH, Noble W (2009) Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol Med 15:112\u2013119. doi: 10.1016\/j.molmed.2009.01.003","journal-title":"Trends Mol Med"},{"key":"458_CR25","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1046\/j.1471-4159.1998.71062465.x","volume":"71","author":"DP Hanger","year":"1998","unstructured":"Hanger DP, Betts JC, Loviny TL, Blackstock WP, Anderton BH (1998) New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry. J Neurochem 71:2465\u20132476","journal-title":"J Neurochem"},{"key":"458_CR26","doi-asserted-by":"publisher","first-page":"23645","DOI":"10.1074\/jbc.M703269200","volume":"282","author":"DP Hanger","year":"2007","unstructured":"Hanger DP, Byers HL, Wray S, Leung KY, Saxton MJ, Seereeram A, Reynolds CH, Ward MA, Anderton BH (2007) Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J Biol Chem 282:23645\u201323654. doi: 10.1074\/jbc.M703269200","journal-title":"J Biol Chem"},{"key":"458_CR27","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1126\/science.282.5395.1914","volume":"282","author":"M Hong","year":"1998","unstructured":"Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI, Geschwind DH, Bird TD, McKeel D, Goate A et al (1998) Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282:1914\u20131917","journal-title":"Science"},{"key":"458_CR28","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/31508","volume":"393","author":"M Hutton","year":"1998","unstructured":"Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A et al (1998) Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702\u2013705","journal-title":"Nature"},{"key":"458_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","volume":"12","author":"K Iqbal","year":"2016","unstructured":"Iqbal K, Liu F, Gong CX (2016) Tau and neurodegenerative disease: the story so far. Nat Rev Neurol 12:15\u201327. doi: 10.1038\/nrneurol.2015.225","journal-title":"Nat Rev Neurol"},{"key":"458_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/jnc.12821","volume":"132","author":"A Ittner","year":"2015","unstructured":"Ittner A, Bertz J, Suh LS, Stevens CH, Gotz J, Ittner LM (2015) Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice. J Neurochem 132:135\u2013145. doi: 10.1111\/jnc.12821","journal-title":"J Neurochem"},{"key":"458_CR31","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","volume":"24","author":"VM-Y Lee","year":"2001","unstructured":"Lee VM-Y, Goedert M, Trojanoswki JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121\u20131159","journal-title":"Annu Rev Neurosci"},{"key":"458_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00401-015-1507-z","volume":"131","author":"J Lewis","year":"2016","unstructured":"Lewis J, Dickson DW (2016) Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 131:27\u201348. doi: 10.1007\/s00401-015-1507-z","journal-title":"Acta Neuropathol"},{"key":"458_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/78078","volume":"25","author":"J Lewis","year":"2000","unstructured":"Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, Gwinn-Hardy K, Paul MM, Baker M, Yu X et al (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet 25:402\u2013405","journal-title":"Nat. Genet"},{"key":"458_CR34","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/prot.24988","volume":"84","author":"TJ Malia","year":"2016","unstructured":"Malia TJ, Teplyakov A, Ernst R, Wu SJ, Lacy ER, Liu X, Vandermeeren M, Mercken M, Luo J, Sweet RW et al (2016) Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti-tau antibody AT8. Proteins 84:427\u2013434. doi: 10.1002\/prot.24988","journal-title":"Proteins"},{"key":"458_CR35","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/cne.21867","volume":"511","author":"P McMillan","year":"2008","unstructured":"McMillan P, Korvatska E, Poorkaj P, Evstafjeva Z, Robinson L, Greenup L, Leverenz J, Schellenberg GD, D'Souza I (2008) Tau isoform regulation is region- and cell-specific in mouse brain. J Comp Neurol 511:788\u2013803. doi: 10.1002\/cne.21867","journal-title":"J Comp Neurol"},{"key":"458_CR36","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1111\/ejn.12229","volume":"37","author":"NV Mohamed","year":"2013","unstructured":"Mohamed NV, Herrou T, Plouffe V, Piperno N, Leclerc N (2013) Spreading of tau pathology in Alzheimer's disease by cell-to-cell transmission. Eur J Neurosci 37:1939\u20131948. doi: 10.1111\/ejn.12229","journal-title":"Eur J Neurosci"},{"key":"458_CR37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/nan.12084","volume":"40","author":"S Mondragon-Rodriguez","year":"2014","unstructured":"Mondragon-Rodriguez S, Perry G, Luna-Munoz J, Acevedo-Aquino MC, Williams S (2014) Phosphorylation of tau protein at sites Ser(396\u2013404) is one of the earliest events in Alzheimer's disease and down syndrome. Neuropathol Appl Neurobiol 40:121\u2013135. doi: 10.1111\/nan.12084","journal-title":"Neuropathol Appl Neurobiol"},{"key":"458_CR38","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1074\/jbc.270.2.823","volume":"270","author":"M Morishima-Kawashima","year":"1995","unstructured":"Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Yoshida H, Titani K, Ihara Y (1995) Proline-directed and non-proline-directed phosphorylation of PHF-tau. J Biol Chem 270:823\u2013829","journal-title":"J Biol Chem"},{"key":"458_CR39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0169-328X(86)90033-1","volume":"387","author":"RL Neve","year":"1986","unstructured":"Neve RL, Harris P, Kosik KS, Kurnit DM, Donlon TA (1986) Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. Brain Res 387:271\u2013280","journal-title":"Brain Res"},{"key":"458_CR40","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/jnr.490390607","volume":"39","author":"L Otvos Jr","year":"1994","unstructured":"Otvos L Jr, Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM-Y (1994) Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 39:669\u2013673","journal-title":"J Neurosci Res"},{"key":"458_CR41","doi-asserted-by":"publisher","first-page":"e94251","DOI":"10.1371\/journal.pone.0094251","volume":"9","author":"FR Petry","year":"2014","unstructured":"Petry FR, Pelletier J, Bretteville A, Morin F, Calon F, Hebert SS, Whittington RA, Planel E (2014) Specificity of anti-tau antibodies when analyzing mice models of Alzheimer's disease: problems and solutions. PLoS One 9:e94251. doi: 10.1371\/journal.pone.0094251","journal-title":"PLoS One"},{"key":"458_CR42","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.bbrc.2007.04.187","volume":"358","author":"R Porzig","year":"2007","unstructured":"Porzig R, Singer D, Hoffmann R (2007) Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein. Biochem Biophy Res Commun 358:644\u2013649. doi: 10.1016\/j.bbrc.2007.04.187","journal-title":"Biochem Biophy Res Commun"},{"key":"458_CR43","doi-asserted-by":"crossref","first-page":"24290","DOI":"10.1016\/S0021-9258(19)51080-8","volume":"269","author":"O Schweers","year":"1994","unstructured":"Schweers O, Schonbrunn-Hanebeck E, Marx A, Mandelkow E (1994) Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure. J Biol Chem 269:24290\u201324297","journal-title":"J Biol Chem"},{"key":"458_CR44","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2174\/156720512800492503","volume":"9","author":"L Troquier","year":"2012","unstructured":"Troquier L, Caillierez R, Burnouf S, Fernandez-Gomez FJ, Grosjean ME, Zommer N, Sergeant N, Schraen-Maschke S, Blum D, Buee L (2012) Targeting phospho-Ser422 by active tau immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach. Curr Alzheimer Res 9:397\u2013405","journal-title":"Curr Alzheimer Res"},{"key":"458_CR45","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.neulet.2014.05.047","volume":"575","author":"KC Walls","year":"2014","unstructured":"Walls KC, Ager RR, Vasilevko V, Cheng D, Medeiros R, LaFerla FM (2014) p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice. Neurosci. Lett 575:96\u2013100. doi: 10.1016\/j.neulet.2014.05.047","journal-title":"Neurosci. Lett"},{"key":"458_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrc.2016.112","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E (2016) Tau in physiology and pathology. Nat Rev Neurosci 17:5\u201321. doi: 10.1038\/nrn.2015.1","journal-title":"Nat Rev Neurosci"},{"key":"458_CR47","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","volume":"72","author":"MD Weingarten","year":"1975","unstructured":"Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A 72:1858\u20131862","journal-title":"Proc Natl Acad Sci U S A"},{"key":"458_CR48","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.neuron.2013.07.046","volume":"80","author":"K Yanamandra","year":"2013","unstructured":"Yanamandra K, Kfoury N, Jiang H, Mahan TE, Ma S, Maloney SE, Wozniak DF, Diamond MI, Holtzman DM (2013) Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo. Neuron 80:402\u2013414. doi: 10.1016\/j.neuron.2013.07.046","journal-title":"Neuron"},{"key":"458_CR49","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC, Maeda J, Suhara T, Trojanowski JQ, Lee VM (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53:337\u2013351","journal-title":"Neuron"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-017-0458-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-017-0458-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-017-0458-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T17:03:19Z","timestamp":1659286999000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-017-0458-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,31]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["458"],"URL":"https:\/\/doi.org\/10.1186\/s40478-017-0458-0","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,31]]},"assertion":[{"value":"12 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.All procedures performed in studies involving animals were in accordance with the ethical standards of the University of Florida.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"58"}}